Mercury Pharmaceuticals

29

Jul 2026

NIH awards $2.4 million to study how maternal viral infections reprogram fetal immune development

The National Institute of Allergy and Infectious Diseases of the National Institutes of Health has awarded a new, five-year $2.4 million R01 grant to Dr. Jiahui Ding, assistant professor of obstetrics and gynecology at the Wayne State University School of Medicine's C.S. Mott Center for Human Growth and Development, to support research that aims to uncover how viral infections during pregnancy reprogram the developing immune system of the fetus, influencing susceptibility to infectious diseases throughout life.

READ MORE

29

Jul 2026

AI-enabled tool helps identify hospitalized patients at risk of rapid clinical decline

Researchers from RWJBarnabas Health and Rutgers Robert Wood Johnson Medical School found that an artificial intelligence (AI)-enabled early warning system helped identify hospitalized patients at risk of rapid clinical decline sooner, contributing to fewer deaths among high-risk patients.

READ MORE

29

Jul 2026

Scientists develop a promising way to create new antifungal drug candidates

Scientists at Imperial College London and The University of Manchester have developed a promising new way to create safer and more effective treatments for life-threatening fungal infections.

READ MORE

29

Jul 2026

Researchers find potential pathway to improve glioblastoma treatment

New research published in Neuro-Oncology gives a glimpse at promising discoveries that could help shape the future of glioblastoma treatment and patient outcomes.

READ MORE

29

Jul 2026

Wildfire evacuation triggered long-term mental health impacts for LA residents

Los Angeles County residents living in evacuation warning or order zones during the 2025 wildfires experienced heightened levels of anxiety and depression almost a year later, according to new USC research.

READ MORE

29

Jul 2026

Immature NK cells in donor cord blood can undermine CAR NK cell therapy activity

The composition of donor cord blood may play a critical role in the success of chimeric antigen receptor (CAR) natural killer (NK) cell therapies.

READ MORE

29

Jul 2026

Climate change shifts malaria risk across sub-Saharan Africa

Malaria is the deadliest climate-sensitive infectious disease. Yet, researchers and public health officials have long argued over how climate change has shaped its spread.

READ MORE

29

Jul 2026

Harvard bioengineers develop a way to quickly create customizable blood vessel grafts

Traumatic injuries, whether on a battlefield or in a car accident, often involve damaged blood vessels that require immediate repair.

READ MORE

29

Jul 2026

New home test uses thigh length to detect type 2 diabetes or prediabetes

A new home test can detect type 2 diabetes or prediabetes with high accuracy. The test has been developed using artificial intelligence and large amounts of health data – and surprisingly, one of the steps involves measuring the length of your thigh.

READ MORE

29

Jul 2026

Deramiocel cell therapy slows muscle and heart damage in advanced DMD

A cell therapy called deramiocel could slow muscle weakening in boys and young men with advanced Duchenne muscular dystrophy (DMD), and may also slow heart damage in those who already have heart muscle disease, a phase 3 clinical trial published in The Lancet has found.

READ MORE